A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Publication/Presentation Date

12-2017

Volume

130

Issue

1

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article

Share

COinS